SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001708599-24-000014
Filing Date
2024-11-06
Accepted
2024-11-06 06:32:10
Documents
23
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A serinatherapeuticsincproxy.htm DEF 14A 495935
2 annexa-serinatherapeuticsi.jpg GRAPHIC 455331
3 annexa-serinatherapeuticsia.jpg GRAPHIC 438901
4 annexa-serinatherapeuticsib.jpg GRAPHIC 334187
5 annexa-serinatherapeuticsic.jpg GRAPHIC 428615
6 annexa-serinatherapeuticsid.jpg GRAPHIC 506574
7 annexa-serinatherapeuticsie.jpg GRAPHIC 482447
8 annexa-serinatherapeuticsif.jpg GRAPHIC 530845
9 annexa-serinatherapeuticsig.jpg GRAPHIC 565311
10 annexa-serinatherapeuticsih.jpg GRAPHIC 552138
11 annexa-serinatherapeuticsii.jpg GRAPHIC 441815
12 annexa-serinatherapeuticsij.jpg GRAPHIC 496577
13 annexa-serinatherapeuticsik.jpg GRAPHIC 473153
14 annexa-serinatherapeuticsil.jpg GRAPHIC 470216
15 annexa-serinatherapeuticsim.jpg GRAPHIC 412286
16 annexa-serinatherapeuticsin.jpg GRAPHIC 523350
17 annexa-serinatherapeuticsio.jpg GRAPHIC 610795
18 annexa-serinatherapeuticsip.jpg GRAPHIC 537734
19 annexa-serinatherapeuticsiq.jpg GRAPHIC 336726
20 proxycard_003.jpg GRAPHIC 574624
21 proxycardimage1.jpg GRAPHIC 74954
22 proxycardimage2.jpg GRAPHIC 217153
23 serinalogo_noaddress.jpg GRAPHIC 9788
  Complete submission text file 0001708599-24-000014.txt   13540422
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38519 | Film No.: 241429156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)